Canopy Growth Corp Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities
Canopy Growth Corp (CGC) reported Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities of -CAD 1.53 million for the 12-month period ending 2018-03-31, per its 40-F filed 2018-06-28.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities · last filed 2018-06-28
| Period end | Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2018-03-31 | -1.53M CAD 40-F · filed 2018-06-28 |
| 2017-03-31 | 2.80M CAD 40-F · filed 2018-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |